[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DE69402004D1 - Beta-mercapto-propanamidderivate verwendbar zur Behandlung kardiovaskularer Krankheiten oder Erkrankungen - Google Patents

Beta-mercapto-propanamidderivate verwendbar zur Behandlung kardiovaskularer Krankheiten oder Erkrankungen

Info

Publication number
DE69402004D1
DE69402004D1 DE69402004T DE69402004T DE69402004D1 DE 69402004 D1 DE69402004 D1 DE 69402004D1 DE 69402004 T DE69402004 T DE 69402004T DE 69402004 T DE69402004 T DE 69402004T DE 69402004 D1 DE69402004 D1 DE 69402004D1
Authority
DE
Germany
Prior art keywords
treatment
cardiovascular diseases
illnesses
mercapto
beta
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69402004T
Other languages
English (en)
Other versions
DE69402004T2 (de
Inventor
Gabriele Norcini
Francesco Santangelo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zambon SpA
Original Assignee
Zambon SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon SpA filed Critical Zambon SpA
Application granted granted Critical
Publication of DE69402004D1 publication Critical patent/DE69402004D1/de
Publication of DE69402004T2 publication Critical patent/DE69402004T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE69402004T 1993-07-30 1994-07-25 Beta-mercapto-propanamidderivate verwendbar zur Behandlung kardiovaskularer Krankheiten oder Erkrankungen Expired - Fee Related DE69402004T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT93MI001723A IT1266571B1 (it) 1993-07-30 1993-07-30 Derivati della beta-mercapto-propanammide utili nel trattamento delle malattie cardiovascolari

Publications (2)

Publication Number Publication Date
DE69402004D1 true DE69402004D1 (de) 1997-04-17
DE69402004T2 DE69402004T2 (de) 1997-06-19

Family

ID=11366739

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69402004T Expired - Fee Related DE69402004T2 (de) 1993-07-30 1994-07-25 Beta-mercapto-propanamidderivate verwendbar zur Behandlung kardiovaskularer Krankheiten oder Erkrankungen

Country Status (5)

Country Link
US (1) US5506259A (de)
EP (1) EP0636621B1 (de)
AT (1) ATE150019T1 (de)
DE (1) DE69402004T2 (de)
IT (1) IT1266571B1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19510566A1 (de) * 1995-03-23 1996-09-26 Kali Chemie Pharma Gmbh Benzazepin-, Benzoxazepin- und Benzothiazepin-N-essigsäurederivate sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
FR2745570B1 (fr) * 1996-03-04 1998-06-19 Roussel Uclaf Nouveaux derives soufres comportant une liaison retroamide, leur procede et intermediaires de preparation, leur application a titre de medicaments, et les compositions pharmaceutiques les renfermant
SE9901573D0 (sv) * 1999-05-03 1999-05-03 Astra Ab New compounds
US7468390B2 (en) 2002-01-17 2008-12-23 Novartis Ag Methods of treatment and pharmaceutical composition
AR057882A1 (es) 2005-11-09 2007-12-26 Novartis Ag Compuestos de accion doble de bloqueadores del receptor de angiotensina e inhibidores de endopeptidasa neutra
RU2667643C2 (ru) 2012-08-24 2018-09-21 Новартис Аг Ингибиторы nep для лечения заболеваний, характеризующихся увеличением или ремоделированием предсердия
WO2017033128A1 (en) 2015-08-25 2017-03-02 Novartis Ag Biphenyl-substitued 4-amino-butyric acid derivatives and their use in the synthesis of nep inhibitors
WO2017072636A1 (en) 2015-10-29 2017-05-04 Cadila Healthcare Limited Pharmaceutical synergistic combination

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1191109B (it) * 1982-12-03 1988-02-24 Simes Derivati di acidi aminopiridincarbossilici,loro metodo di sintesi e composizioni farmaceutiche che li contengono
FR2540495B1 (fr) * 1983-02-07 1986-02-14 Roussel Uclaf Nouveaux derives de o-mercaptopropanamide et de ses homologues, leur procede de preparation, leur application comme medicaments, les compositions les renfermant et les nouveaux intermediaires obtenus
EP0136883B1 (de) * 1983-10-03 1987-11-25 E.R. Squibb & Sons, Inc. Enkephalinase Inhibitoren
FR2611712B1 (fr) * 1987-02-26 1989-06-23 Roussel Uclaf Nouveaux derives n-substitues de l'alpha-mercaptomethyl benzene propanamide, leur procede de preparation, leur application a titre de medicaments et les compositions les renfermant
EP0318859A3 (de) * 1987-12-03 1990-08-16 Dainippon Pharmaceutical Co., Ltd. N-Substituierte Mercaptopropionamid-Derivate
US4879309A (en) * 1988-09-27 1989-11-07 Schering Corporation Mercapto-acylamino acids as antihypertensives
EP0361365A1 (de) * 1988-09-30 1990-04-04 E.R. SQUIBB & SONS, INC. Derivate von Aminobenzoesäure und Aminocyclohexancarbonsäure, Zusammensetzungen und ihre Verwendung
GB9123353D0 (en) * 1991-11-04 1991-12-18 Fujisawa Pharmaceutical Co New mercapto-amide derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same
GB2272435A (en) * 1992-11-16 1994-05-18 Fujisawa Pharmaceutical Co WS75624 substances from saccharothrix strain

Also Published As

Publication number Publication date
ITMI931723A1 (it) 1995-01-30
IT1266571B1 (it) 1997-01-09
EP0636621A1 (de) 1995-02-01
US5506259A (en) 1996-04-09
EP0636621B1 (de) 1997-03-12
DE69402004T2 (de) 1997-06-19
ITMI931723A0 (it) 1993-07-30
ATE150019T1 (de) 1997-03-15

Similar Documents

Publication Publication Date Title
ATE337316T1 (de) Imidazo 1,2-aöpyridin-derivate zur prophylaxe und behandlung von herpes-infektionen
DE60204452D1 (de) Pyrazolo[1,5]pyridinderivate
NO302474B1 (no) Sakarinderivater, farmasöytisk sammensetning og anvendelse derav
ECSP045378A (es) Derivados novedosos de diazabiciclononeno
SE8404065D0 (sv) Novel biologically active compounds
DE3882679D1 (de) Kardiovaskulaer aktive verbindungen.
NO20010940D0 (no) TAN-1057 derivater
DE69218816D1 (de) N-acetyl-cysteine Derivate enthaltende pharmazeutische Zusammensetzung zur Behandlung von Katarakt
DE69402004D1 (de) Beta-mercapto-propanamidderivate verwendbar zur Behandlung kardiovaskularer Krankheiten oder Erkrankungen
SE8600658D0 (sv) Novel composition of matter
DE69210091D1 (de) Leukotrien-B4-Antagonisten
ATE179424T1 (de) N-heteroaryl substituierte propanamid-derivate brauchbar zur behandlung cardiovascularer krankheiten
UA48958C2 (uk) 9-o-оксимові похідні еритроміцину а та фармацевтична композиція на їх основі
IT1216104B (it) Peptidi ad attivita' farmaceutica.
ATE88176T1 (de) 2-hydroxy-3-aryloxy-propylaminderivate mit kardiovaskulaerer wirkung.
DK0805817T3 (da) Thiolderivater med metallopeptidaseinhiberende aktivitet
IL89537A0 (en) Peptides,their preparation and pharmaceutical compositions containing them
IT1277736B1 (it) Derivati tiolici ad attivita' inibitrice delle metallopeptidasi
DE3882677D1 (de) Kardiovaskulaer aktive verbindungen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee